α2-adrenoceptor agonists: Shedding light on neuroprotection?

British Medical Bulletin

Volumn 71, Issue , 2004, Pages 77-92

  Ma, Daqing ^a,b   Rajakumaraswamy, Nishanthan ^a   Maze, Mervyn ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATIPAMEZOLE; CALCIUM ION; CLONIDINE; DEXMEDETOMIDINE; GLUTAMATE RECEPTOR ANTAGONIST; IBOTENIC ACID; IMIDAZOLINE RECEPTOR; PROTEIN BCL 2; RILMENIDINE; YOHIMBINE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CATECHOLAMINE; DRUG RECEPTOR; GLUTAMIC ACID DERIVATIVE; IMIDAZOLINE RECEPTORS; NEUROPROTECTIVE AGENT;

ADRENERGIC TRANSMISSION; ALPHA ADRENERGIC STIMULATION; ANALGESIA; ANESTHESIA; BIOCHEMISTRY; BRADYCARDIA; CLINICAL RESEARCH; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; EVALUATION; HUMAN; HYPOTENSION; IN VITRO STUDY; IN VIVO STUDY; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW; SEDATION; TRANQUILIZING ACTIVITY; ANIMAL; APOPTOSIS; ASTROCYTE; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; NERVE CELL; VASOCONSTRICTION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; APOPTOSIS; ASTROCYTES; CALCIUM; CATECHOLAMINES; GLUTAMATES; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG; VASOCONSTRICTION;

EID: 16444385621     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/bmb/ldh036     Document Type: Review

References (48)

1. 2-adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology, 74, 581-605.
2. 2- adrenergic agonists. Anesthesiology 2000, 93, 1345-1349.
3. Khan ZP, Ferguson CN, Jones RM (1999) Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia, 54, 146-165.
4. Werner C, Hoffman WE, Thomas C, Miletich DJ, Albrecht RF (1990) Ganglionic blockade improves neurologic outcome from incomplete ischemia in rats: partial reversal by exogenous catecholamines. Anesthesiology, 73, 923-929.
5. Globus MY, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg MD (1988) Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia. Neurosci Lett, 91, 36-40.
6. Hoffman WE, Cheng MA, Thomas C, Baughman VL, Albrecht RF (1991) Clonidine decreases plasma catecholamines and improves outcome from incomplete ischemia in the rat. Anesth Analg, 73, 460-464.
7. Hoffman WE, Kochs E, Werner C, Thomas C, Albrecht RF (1991) Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat: reversal by the a2-adrenergic antagonist atipamezole. Anesthesiology, 75, 328-332.
8. Hoffman WE, Baughman VL, Albrecht RF (1993) Interaction of catecholamines and nitrous oxide ventilation during incomplete brain ischemia in rats. Anesth Analg, 77, 908-912.
9. 2-adrenoceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology, 79, 300-312.
10. 2-Adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage. Brain Res, 693, 217-224.
11. Kuhmonen J, Pokorny J, Miettinen R et al. (1997) Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology, 87, 371-377.
12. Choi DW, Rothman SM (1990) The role of glutamate neurotoxicity in hypoxic-ischaemic neuronal death. Annu Rev. Neurosci, 13, 171-182.
13. 2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur J Pharmacol, 372, 31-36.
14. Seidler FJ, Slotkin TA (1985) Adrenomedullary function in the neonatal rat: responses to acute hypoxia. J Physiol, 358, 116.
15. Yuan SZ, Runold M, Hagberg H, Bona E, Lagercrantz H (2001) Hypoxic-ischaemic brain damage in immature rats: effects of adrenoceptor modulation. Eur J Pediatr Neurol, 5, 29-35.
16. 2-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine. Anesthesiology, 96, 134-141.
17. Shibata S, Kodama K, Tominaga K, Ueki S, Watanabe S (1992) Assessment of the role of adrenoceptor function in ischemia-induced impairment of 2-deoxyglucose uptake and CAl field potential in rat hippocampal slices. Eur J Pharmacol, 221, 255-260.
18. 2A-adrenoceptor subtype. Eur J Pharmacol, 502, 87-97.
19. Weinberger R, Neives-Rosa J (1988) Monoamine neurotransmitters in the evolution of infarction in ischemic striatum: morphologic correlation. J Neural Trans, 71, 133-142.
20. Simonson SG, Zhang J, Canada AT Jr, Su Y-F, Benvensiste H, Piantadosi PA (1993) Hydrogen peroxide production by monoamine oxidase during ischemia-reperfusion in the rat brain. J Cereb Blood Flow Metab, 13, 125-134.
21. Miyazaki M, Nazarali AJ, Boisvert DP, Bayens-Simmonds J, Baker GB (1989) Inhibition of ischemia-induced brain catecholamine alterations by clonidine. Brain Res Bull, 22, 207-211.
22. 2- adrenergic agonist, dexmedetomidine, selectively attenuates ischemia-induced increases in striatal norepinephrine concentrations. Brain Res, 627, 325-329.
23. 2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology, 96, 450-457.
24. Nellgard BMG, Miura Y, Mackensen B, Pearlstein RD, Warner DS (1999) Effect of intracerebral norepinephrine depletion on outcome from severe forebrain ischemia in the rat. Brain Res, 262-269.
25. 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg, 71, 125-129.
26. Krugers HJ, Kemper RHA, Korf J, Ter Horst GJ, Knooema S (1998) Metyrapone reduces rat brain damage and seizures after hypoxia-ischemia: an effect independent of modulation of plasma corticosterone levels?. J Cereb Blood Flow Metab, 18, 386-390.
27. Group THACAS (2002) Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med, 346, 549-556.
28. Vizi ES (2000) Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. Pharmacol Rev, 52, 63-89.
29. Madison DV, Nicoll RA (1986) Actions of noradrenaline recorded intracellularly in rat hippocampal pyramidal neurones in vitro. J Physiol, 372, 221-244.
30. 2-Adrenergic agonists reduce glutamate release and glutamate receptor mediated calcium changes in hippocampal slices during hypoxia. Neuropharmacology, 35, 679-687.
31. Milusheva EA, Baranyi M (2003) Implication of ionotropic glutamate receptors in the release of noradrenaline in hippocampal CA1 and CA3 subregions under oxygen and glucose deprivation. Neurochem Int, 43, 543-550.
32. Talke P, Bickler PE (1996) Effects of dexmedetomidine on hypoxia-evoked glutamate release and glutamate receptor activity in hippocampal slices. Anesthesiology, 85, 551-557.
33. Choi DW (1995) Calcium: still center-stage in hypoxic-ischaemic neuronal death. Trends Neurosci, 18, 58-60.
34. 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg, 96, 524-531.
35. 2- adrenoceptor agonist, dexmedetomidine, alters acute gene expression after global ischemia in gerbils. Neurosci Lett, 232, 75-78.
36. Mizuki T, Kobasyashi H, Ueno S et al. (1995) Differential changes in alpha- and beta-adrenoceptors in the cerebral cortex and hippocampus of the Mongolian gerbil after unilateral brain ischemia. Stroke, 26, 2333-2336.
37. Huang R, Chen Y, Yu ACH, Hertz L (2000) Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes: a possible mechanism for its neuroprotective activity. J Cereb Blood Flow Metab, 20, 895-898.
38. Maiese K, Pek L, Berger SB, Reis DJ (1992) Reduction in focal cerebral ischemia by agents acting at imidazole receptors. J Cereb Blood Flow Metab, 12, 53-63.
39. MacMillan LB, Hein L, Smith MS, Piascik MT, Limbird LE (1996) Central hypotensive effects of the alpha2A-adrenergic receptor subtype. Science, 273, 801-803.
40. 2A-adrenergic receptor knockout mice. Mol Pharmacol, 56,154-161.
41. 2c, inhibit transmitter release in the brain of gene-targeted mice. Neuroscience, 109, 819-826.
42. Coursin DB, Coursin DB, Maccioli GA (2001) Dexmedetomidine Curr Opin Crit Care, 7, 221-226.
43. Karlsson BR, Loberg EM, Steen PA (1995) Dexmedetomidine, a potent alpha 2-agonist, does not affect neuronal damage following severe forebrain ischaemia in the rat. Eur J Anaesthesiol, 12, 281-285.
44. Kuhmonen J, Haapalinna A, Sivenius J (2001) Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat. J Neural Transm, 108, 261-271.
45. Talke P, Li J, Jain U, Leung J, Drasner K, Hollenberg M, Mangano DT (1995) Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology, 82, 620-633.
46. Dorman BH, Zucker J, Verrier ED, Gartman DM, Slachman FN (1993) Clonidine improves perioperative myocardial ischemia, reduces anesthetic requirements, and alters haemodynamic parameters in patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth, 7, 386-395.
47. Jaionen J, Hynynen M, Kuitunen A et al. (1997) Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology, 86, 331-345.
48. Talke P (1998) Receptors-specific reversible sedation: beginning of new era of anesthesia: Anesthesiology, 89, 560-561.